PPM Oost and Wageningen University and Research Center have sold their stakes in the biotech incubator BioPartner Wageningen Center to developer and investor Kadans Vastgoed.
EQT IX is expected to be 70-75% invested following the deal
Previous fund held a final close in 2012 with capital commitments of USD 840m
MoU marks LBO France's first foray into the Chinese market, with plans to open a local office
ECI bought the asset from Phoenix less than three years ago